Affordable Access

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.

Authors
Type
Published Article
Journal
Neurology
Publication Date
Volume
51
Issue
3
Pages
773–781
Identifiers
PMID: 9748025
Source
Medline

Abstract

Rizatriptan 10 mg PO is efficacious and generally well tolerated in acute migraine. Its efficacy is maintained throughout the treatment of multiple, discrete migraine attacks.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments